Home / Drug shortages / Pentamidine Isethionate Injection

Pentamidine Isethionate Injection — FDA Drug Shortage

To Be Discontinued — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Pentamidine Isethionate Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status To Be Discontinued. The shortage was first posted on 03/23/2026.

Shortage Details

Status
To Be Discontinued
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-3050-2
Dosage Form
Injection
Presentation
Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)
Initial Posting
03/23/2026
Revised Date

FDA data resources